BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14986830)

  • 1. Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland.
    Janiszewska H; Haus O; Lauda-Swieciak A; Pasińska M; Laskowski R; Szymański W; Górski B; Lubiński J
    Clin Genet; 2003 Dec; 64(6):502-8. PubMed ID: 14986830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
    Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
    Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B
    Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary ovarian cancer in Poland.
    Menkiszak J; Gronwald J; Górski B; Jakubowska A; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Haus O; Janiszewska H; Perkowska M; Brozek I; Grzybowska E; Zientek H; Góźdź S; Kozak-Klonowska B; Urbański K; Miturski R; Kowalczyk J; Pluzańska A; Niepsuj S; Koc J; Szwiec M; Drosik K; Mackiewicz A; Lamperska K; Strózyk E; Godlewski D; Stawicka M; Waśko B; Bebenek M; Rozmiarek A; Rzepka-Górska I; Narod SA; Lubiński J
    Int J Cancer; 2003 Oct; 106(6):942-5. PubMed ID: 12918074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009].
    Blecharz P; Szatkowski W; Klimek M; Urbański K
    Przegl Lek; 2009; 66(12):1046-8. PubMed ID: 20514903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
    Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
    Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.
    Skasko E; Paszko Z; Niwińska A; Kwiatkowska E; Kruczek A; Pieńkowski T
    Eur J Gynaecol Oncol; 2004; 25(4):470-4. PubMed ID: 15285306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the most frequent BRCA1 mutations in Polish population.
    Brozek I; Cybulska C; Ratajska M; Piatkowska M; Kluska A; Balabas A; Dabrowska M; Nowakowska D; Niwinska A; Pamula-Pilat J; Tecza K; Pekala W; Rembowska J; Nowicka K; Mosor M; Januszkiewicz-Lewandowska D; Rachtan J; Grzybowska E; Nowak J; Steffen J; Limon J
    J Appl Genet; 2011 Aug; 52(3):325-30. PubMed ID: 21503673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
    Szwiec M; Jakubowska A; Górski B; Huzarski T; Tomiczek-Szwiec J; Gronwald J; Dębniak T; Byrski T; Kluźniak W; Wokołorczyk D; Birkenfeld B; Akbari MR; Narod SA; Lubiński J; Cybulski C
    Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.
    Brozek I; Ratajska M; Piatkowska M; Kluska A; Balabas A; Dabrowska M; Nowakowska D; Niwinska A; Rachtan J; Steffen J; Limon J
    Fam Cancer; 2012 Sep; 11(3):351-4. PubMed ID: 22395474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].
    Tao T; Yang JX; Shen K; Cao DY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):20-25. PubMed ID: 28190311
    [No Abstract]   [Full Text] [Related]  

  • 18. Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.
    Bruchim I; Fishman A; Friedman E; Goldberg I; Chetrit A; Barshack I; Dekel E; Hirsh-Yechezkel G; Modan B; Kopolovic J
    Int J Gynecol Cancer; 2004; 14(2):251-8. PubMed ID: 15086724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.